Global Sample Preparation System for IVD Market Size Likely to Grows at a CAGR of 8.2% By 2035

The IVD market of Sample Preparation Systems in the world is predicted to be USD 7.15 billion in 2025 and is anticipated to grow to approximately USD 7.71 billion in 2026, and even further rising to about USD 15.81 billion in 2035 at a CAGR of 8.2% between the years of 2026 and 2035.

Sample Preparation System for IVD market Revenue and Trends

The IVD market of Sample Preparation System is a critical component of the overall diagnostics business, as it provides the opportunity to process the biological samples correctly and effectively to be used in the following areas: molecular diagnostics, infectious disease tests, and oncology. The market is showing a consistent growth with the growing demand of high-throughput and automated laboratory processes, the growing incidence of chronic and infectious diseases, and the growing attention to early and accurate detection of diseases.

New technologies such as PCR and next-generation sequencing (NGS) and the transition to integrated and error-free sample processing are further increasing adoption. Also, there are other factors contributing to the long-term market growth in the form of expanding the healthcare infrastructure, investments in the diagnostic capabilities, and tense government support in areas like Asia Pacific, North America and Europe and the continuous innovation of the reagents, consumables and compact systems are increasing the efficiency and accessibility.

What are the Factors that Substantially Contribute to the Development of the Sample Preparation System for IVD market?

The development of the Sample Preparation System of IVD market is mainly caused by the increasing demand of the high-throughput, accurate and rapid diagnostic testing in the world. The growing rate of infection diseases, cancer, and genetic disorders have made it a great demand to have a dependable sample processing to achieve accurate diagnostic results. The growth of molecular diagnostics such as PCR and next-generation sequencing (NGS) has only deepened the significance of an effective system of sample preparation to the clinical workflow. Also, the move towards the automation of laboratories and the development of sample-to-result solutions is increasing efficiency, decreasing human error, and increasing turnaround time, accelerating its acceptance in both diagnostic labs and hospitals.

The market is also growing due to the technological and the necessity of the standardized and reproducible results. One of the ways to improve the quality of samples and the efficiency of their processing is through innovations in automated systems, extraction using magnetic beads, and microfluidic technologies. Simultaneously, more precise medicine and personalized healthcare is also necessitating the development of sophisticated sample preparation solutions. Moreover, the growth of healthcare facilities, increased investment on diagnostic potentials and increased sensitization on early disease detection is favouring market growth in the long-term, and the same constant growth in reagents and consumables is guaranteeing steady demand and growth.

Segment Insight

By Product Type

Sample Preparation System IVD Automated Sample Preparation Systems prevail in the Sample Preparation System IVD market because of increasing demand of high-throughput testing, less human error and increased workflow efficiency of diagnostic laboratories. These systems are used in large scale labs and hospitals where standard and fast processing is needed. Manual Sample Preparation Kits have not lost their usefulness at least in a small laboratory or resource constrained environment where cost is a critical factor. Reagents and Consumables is a steadily increasing market segment, with their repeated use in each test cycle, which guarantees a constant demand, as well as the growth in the diagnostic testing volumes.

By Application

Clinical Diagnostics dominates the market because the preparation of samples is an important process of daily disease diagnosis and patient checks. Molecular Diagnostics has regained its current boom and surge due to the increased use of technology in the field including PCR, next-generation sequencing (NGS), particularly to target precision medicine. The Testing of Infectious Diseases has been experiencing a great force the increased burden of diseases across the globe and the necessity of faster and more accurate ways of detecting diseases. Oncology Testing is also growing at a tremendous pace with the increased attention to the treatment of cancer in its early stages and the individual approach to the treatment, whereas other applications remain reliable contributors to the market growth.

By End-User

The highest percentage of the market is held by Diagnostic Laboratories because of the high number of tests and the growing number of automation to enhance efficiency and turnaround time. Hospitals are also another major contributor because they have advanced diagnostic systems that are incorporated to assist in the care and testing of patients on-site. Research Institutes contribute to innovation as well as creation of new diagnostic methods, thus aiding the need to have high level of sample preparation systems in experimental and clinical study settings.

By Region

North America is the global leader in the Sample Preparation System of IVD, because it has developed excellent healthcare facilities with high rate of automated diagnostics and high investment in R&D. Europe is experiencing stable growth and an established base of laboratories and emphasis on early disease detection and quality. Asia Pacific is the region which is rapidly expanding because of emerging and developing healthcare infrastructures, the growing disease prevalence, and the awareness in such countries as China and India. Meanwhile, gradual growth is observed in Latin America and the Middle East as well as Africa because of the increasing access to healthcare and increasing investments in diagnostic facilities.

Report Scope

Recent Developments

• Bio-Rad Laboratories on July 2023 issued new sample preparation kits to maximize the performance of nucleic acid extraction to meet the increasing demand by diagnostic laboratories and research facilities.

List of the prominent players in the Sample Preparation System for IVD Market:

• Thermo Fisher Scientific

• QIAGEN

• Roche

• Agilent Technologies

• Danaher Corporation

• Bio-Rad Laboratories

• PerkinElmer

• Illumina

• Merck KGaA

• Becton Dickinson and Company

• Tecan Group

• Sartorius

• Others

The Sample Preparation System for IVD Market is segmented as follows:

By Product Type

• Automated Sample Preparation Systems

• Manual Sample Preparation Kits

• Reagents and Consumables

By Application

• Clinical Diagnostics

• Molecular Diagnostics

• Infectious Disease Testing

• Oncology Testing

• Others

By End-User

• Hospitals

• Diagnostic Laboratories

• Research Institutes

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America